Biotech

All Articles

FibroGen gives up 75% people staff as asset fails 2 more tests

.FibroGen is significantly restructuring its own business, laying off 75% of its U.S. team and stopp...

Tracon wane full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has chosen to unwind procedures weeks after an injectable immune gate preven...

Ideaya bags option on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M reduction on failed epilepsy medicine, proclaims FDA operate

.Our company actually understand that Takeda is hoping to find a road to the FDA for epilepsy medica...

VBI Vaccinations declare insolvency, seeks possession purchase

.Immunology biotech VBI Vaccinations is actually turning alarmingly near the moment of truth, along ...

Celldex anti-cKIT antitoxin lessen hives in yet another phase 2 research study

.It's not easy to muscle in on a room as affordable as immunology, but Celldex Therapies feels that ...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies and also a preclin...

Ventyx's last resort for inflamed med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's health condition medication carried out not aid people attain remission...

Cognition's phase 2 SHINE data tarnish Alzheimer's possibility

.Knowledge Therapies' period 2 SHINE trial has actually taken some of the appeal off the Alzheimer's...

BMS axes bispecific months after filing to function stage 3 test

.Bristol Myers Squibb has possessed a whiplash change of heart on its BCMA bispecific T-cell engager...